Clinical significance of BRAF mutations in metastatic melanoma

Forty to eighty percent of melanoma tumors have activating mutations in BRAF although the clinical importance of these mutations is not clear. We previously reported an analysis of BRAF mutations in metastatic melanoma samples from 68 patients. In this study, we correlated patient baseline character...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chang, David Z, Panageas, Katherine S, Osman, Iman, Polsky, David, Busam, Klaus, Chapman, Paul B
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2004
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC544849/
https://ncbi.nlm.nih.gov/pubmed/15613230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-46
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars